Abstract
The intracisternal administration of 5,7-dihydroxytryptamine (5,7-DHT) to rats resulted in a potentiated response to 5-hydroxytryptophan (5-HTP) when the animals were tested 30 days later. The 5-HTP-induced changes include elevation of serum prolactin decrease in operant responding, and the magnitude of the “serotonin behavioral syndrome” observed after 5-HTP administration. The serotonin concentration in brains of 5,7-DHT-treated animals reached maximum earlier and remained elevated longer than that of controls following administration of 5-HTP. Brain norepinephrine and dopamine concentration were not affected by 5-HTP in either group of animals. The increase in serum prolactin concentration elicited by administration of the serotonergic agonists quipazine or 5-methyxy-N,N-dimethyltryptamine and by the serotonin uptake inhibitor fenfluramine also was potentiated by pretreating rats with 5,7-DHT. These data suggest that both serotonergic receptor supersensitivity and the absence of presynaptic uptake sites contribute to the enhanced responses to 5-HTP occurring in rats previously treated with 5,7-DHT. The findings further demonstrate that both behavioral and hormonal measures can be used to assess the sensitivity of serotonergic receptors and indicate that 5,7-DHT may be useful in evaluating the role of serotonergic neurons in neuroendocrine function.
Similar content being viewed by others
References
Advis JP, Simpkins JW, Meites J (1979) Serotonergic control of prolactin release in male rats Life Sci 24:359–366
Baumgarten HG, Lachenmayer L (1972) 5,7-Dihydroxytryptamine: Improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z Mikroscop Anat Forsch 135:399–414
Baumgarten HG, Bjorklund A, Sachenmayer L, Nobin A (1973) Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta Physiol Scand (Suppl) 391:1–19
Bogdanski DR, Pletscher A, Brodie BB, Udenfriend S (1956) Identification and assay of serotonin in brain. J Pharmacol Exp Ther 117:82–88
Breese GR, Cooper BR (1975) Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs, when administered intracisternally to adult and developing rats. Brain Res 98:517–527
Breese GR, Mueller RA (1978) Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacological agents in adult and developing rats. Ann NY Acad Sci 305:160–174
Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413–420
Breese GR, Vogel RA, Kuhn CM, Mailman RB, Mueller RA, Schanberg SM (1978) Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine. Brain Res 155:263–275
Brodie BB, Comer MS, Costa E, Dlabac A (1966) The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther 152:340–349
Butcher LL, Engel J, Fuxe K (1972) Behavioral, biochemical and histochemical analysis after peripheral decarboxylase inhibition. Brain Res 41:387–411
Chen HG, Meites G (1975) Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology 96:10–14
Clemens JA (1978) Effects of serotonin neurotoxins on pituitary hormone release. Ann NY Acad Sci 305:399–410
Clemens JA, Sawyer BD, Cerimele B (1977) Further evidence that serotonin in a neurotransmitter involved in the control of prolactin secretion. Endocronilogy 100:692–698
Costa E, Groppetti A, Revuelta A (1971) Action of fenfluramine on monoamine stores of rat tissue. Br J Pharmacol 41:57–64
Daly J, Fuxe K, Jonsson J (1974) 5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydryxytryptamine neurons. Res Commun Chem Pathol Pharmacol 7:175–187
Dickerman S, Kledzik G, Gelato M, Chen HJ, Meites J (1974) Effects of haloperidol on serum and pituitary prolactin, LH, FSH, and hypothalamic PIF and LRF. Neuroendocrinology 15:10–20
Fessler RG, Meltzer HY (1979) Effect of electrolytic lesions of the medial raphe nucleus on 5-HTP and LU10-171 induced increases in serum prolactin levels in rats. Neurosci Abstr 1563, vol 5
Fuller RW, Perry KW, Clemens JA (1976) Elevation of 3,4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: Evidence for antagonism at dopamine receptor sites. J Pharm Pharmacol 28:643–644
Fuxe K, Holmstedt B, Jonsson J (1972) Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons. Eur J Pharmacol 19:25–34
Gerson S, Baldessarini RJ (1975) Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine. Brain Res 85:140–145
Gil-Ad I, Zambotti F, Carruba MO, Vicentini L, Muller EE (1976) Stimulatory role for brain serotonergic system in prolactin secretion in the male rat. Proc Soc Exp Biol Med 151:512–518
Hole K, Fuxe K, Jonsson G (1976) Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways. Brain Res 107:385–399
Honig E, Sancilio RL, Vargas R, Pardo EG (1969) Similarities between the pharmacological actions of quipazine and serotonin. Eur J Pharmacol 6:274–280
Hunter WM, Greenwood FC (1962) Preparation of iodine-131-labelled human growth hormone on high specific activity. Nature 194:495–496
Kamberi IA, Mical RA, Porter JC (1971) Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology 88:1288–1293
Kizer JS, Zivin JA, Jacobowitz DM, Kopin IJ (1975) The nyctohemeral rhythm of plasma prolactin: Effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. Endocrinology 96:1230–1240
Knapp S, Mandell AJ (1976) Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: Effect of fenfluramine. J Pharmacol Expl Ther 198:123–132
Kordon C, Blake J, Sawyer CH (1973) Participation of serotonincontaining neurons in the suckling-induced rise in plasma prolactin levels in lactating rats. Neuroendocrinology 13:213–223
Krulich L (1975) The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat. Life Sci 17:1141–1144
Lawson DM, Gala RR (1973) The influence of adrenergic, dopaminergic, cholinergic and serotonergic drugs on plasma prolactin levels in ovariecotomized estrogen-treated rats. Endocrinology 96:152–155
Lorens SA, Guldberg HC, Hole K, Kohler C, Srebro B (1979) Activity, avoidance learning and regional 5-hydroxytyrptamine following intra-brainstem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res 108:97–113
Lu KH, Meites J (1973) Effects of serotonin precursors and melatonin on serum prolactin release in rats. Endocrinology 93:152–155
McLeod RM Lamberts SWJ (1978) Regulation of prolactin secretion by dopamine and serotonin related drugs. In: Robyn C, Harter M (eds) Progress in prolactin physiology and pathology, Elsevier, New York, pp 111–116
Meltzer HY, Fang VS, Paul SM, Kaluskar R (1976) Effect of quipazine on rat plasma prolactin levels. Life Sci 19:1073–1078
Meltzer HY, Fessler RG, Simonovich M, Fang VS (1977) Effect of indole hallucinogens, mescaline and DMPEA on rat plasma prolactin. Fed Proc 36:984
Morgan WW, Herbert DC (1978) Elevation of serum prolactin levels after the inhibition of serotonin uptake. Endocrinology 103:1016–1022
Nelson DL, Herbert A, Bourgoing S, Glowinski J, Hamon M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihyroxytryptamine administration in the rat. Mol Pharmacol 14:963–995
Ng LKY, Chase TN, Colburn RW, Kopin IJ (1972) Release of 3H-dopamine by l-5-hydroxytryptophan. Brain Res 45:499–505
Ohgo S, Kato Y, Chihara K, Imura H, Maeda K (1976) Effect of hypothalamic surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats. Endocrinol J 23:485–491
Ojeda SR, Harms PG, McCann SM (1976) Effect of blockade of dopaminergic receptors on prolactin and LH release: Median eminence and pituitary sites of action. Endocrinology 94:1650–1657
Rodriguez R, Rojos Ramirez J, Drucker-Colin R (1973) Serotonin-like actions of quipazine on the central nervous system. Eur J Pharmacol 24:164–171
Smith JE, Lane JD, Shea PA, McBride WJ (1977) Neurochemical changes following administration of precursor of biogenic amines. Life Sci 21:301–306
Stewart RM, Growdon JH, Cancian D, Baldessarini RJ (1976) 5-Hydroxytryptophan-induced myoclonus: Increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology 15:449–455
Subramania MG, Gala RR (1976) The influence of cholinergic, adrenergic and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized estrogen-treated rats. Endocrinology 98:842–848
Trulson ME, Eubanks EE, Jacobs BL (1976) Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J Pharmacol Expl Ther 198:23–32
Winter JC (1969) Behavioral effects of N,N-diethyltryptamine: Absence of antagonism by xylamidine tosylate. J Pharmacol Exp Ther 169:7–16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuhn, C.M., Vogel, R.A., Mailman, R.B. et al. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology 73, 188–193 (1981). https://doi.org/10.1007/BF00429216
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00429216